VHAM
JAZZ icon

Van Hulzen Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Van Hulzen Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50
Closed -$6.16K – 712
2024
Q4 		$6.16K Buy
+50
New +$5.89K ﹤0.01% 826
2023
Q1 		– Sell
-2,631
Closed -$419K – 314
2022
Q4 		$419K Buy
2,631
+109
+4% +$16K 0.05% 195
2022
Q3 		$336K Sell
2,522
-3,145
-55% -$478K 0.04% 200
2022
Q2 		$884K Sell
5,667
-412
-7% -$63.4K 0.11% 118
2022
Q1 		$946K Buy
6,079
+207
+4% +$30K 0.1% 118
2021
Q4 		$748K Buy
5,872
+1,095
+23% +$144K 0.08% 138
2021
Q3 		$622K Buy
4,777
+1,931
+68% +$292K 0.09% 121
2021
Q2 		$506K Buy
2,846
+189
+7% +$32.7K 0.08% 147
2021
Q1 		$437K Buy
2,657
+40
+2% +$6.58K 0.07% 159
2020
Q4 		$432K Buy
2,617
+98
+4% +$14.6K 0.07% 159
2020
Q3 		$359K Buy
+2,519
New +$312K 0.05% 172
2020
Q1 		– Sell
-10,460
Closed -$1.56M – 272
2019
Q4 		$1.56M Buy
+10,460
New +$1.42M 0.3% 72

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Van Hulzen Asset Management's JAZZ Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 50 shares — an estimated $6.16K sold.

Van Hulzen Asset Management first reported a position in JAZZ in Q4 2019 and held it in 12 quarters. The position peaked at $1.56M in Q4 2019. 551 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • Van Hulzen Asset Management reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Van Hulzen Asset Management sold 50 Jazz Pharmaceuticals shares in Q1 2025, an estimated $6.16K.
  • Van Hulzen Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 12 quarters.
  • Van Hulzen Asset Management's Jazz Pharmaceuticals position peaked at $1.56M in Q4 2019.
  • 551 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.